O'Hearn Named CCO of Surgical Innovation Associates

Industry veteran to lead global commercialization of soft tissue support products in plastic surgery

Jason O'Hearn

Surgical Innovation Associates (SIA) has announced the appointment of Jason O’Hearn as chief commercial officer. O’Hearn brings more than 25 years of experience in commercial organizations for aesthetic and regenerative medical devices to the position. He previously held executive roles within Sientra and Mentor Corporation, a division of Johnson & Johnson. He has led global sales, including both the introduction of new brands and the growth of market-leading devices, within the reconstructive and plastic surgery market.

“Jason has demonstrated the ability to create value and accumulate market share in the highly competitive aesthetics market,” said Ryan Egeland, MD, PhD, SIA investor and Board Director, “He brings a trusted name and a wealth of diverse but sector-specific expertise to the SIA management team during this important commercial transition for the company.”

“I am very happy to join the talented and dedicated team at SIA,” said O’Hearn, who holds a BA in Business Management with a minor in Finance from San Diego State University. “Our flagship product, DuraSorb, will transform the use of soft tissue support to provide patients with long-lasting and predictable outcomes.”

More in News